What Vaccine Options Are Most Likely to Protect Us Against COVID-19?

August 24, 2020

The Sigma Xi Committee on Lectureships is hosting a series of lectures to address the COVID-19 pandemic. Join the first discussion on Zoom on Friday, August 28, from 2:00 p.m.–3:00 p.m. ET to hear a virologist discuss what vaccine options are most likely to protect us against COVID-19.

Mark Peeples Speaker: Mark Peeples, PhD, principal investigator and member of the Center for Vaccines and Immunity at The Research Institute at Nationwide Children's Hospital, and a professor of Pediatrics and of Molecular & Cellular Biochemistry at The Ohio State University College of Medicine. Sigma Xi Past President and Fellow. 

Abstract: SARS-CoV-2 is washing over the world like a tsunami. How do you stop a tsunami? The development of treatments for COVID-19's most consequential symptoms come first, as they are tested in the hospital setting. Antiviral agents and vaccines take more time and are currently under development in many academic and pharmaceutical institutions. Vaccines hold the greatest promise for protecting the population because they are preventive. This discussion will review the different approaches to vaccine development, and their strengths and weaknesses, and the role of the virus target in the process.

Register at this link. Zoom information will be sent two days before the session.

Cost: Free

Feel free to share this information with colleagues. Contact lectureships@sigmaxi.org with questions.

Pictured above: Mark Peeples 


More About Sigma Xi: Sigma Xi, The Scientific Research Honor Society is the world’s largest multidisciplinary honor society for scientists and engineers. Its mission is to enhance the health of the research enterprise, foster integrity in science and engineering, and promote the public understanding of science for the purpose of improving the human condition. Sigma Xi chapters can be found at colleges and universities, government laboratories, and industry research centers around the world. More than 200 Nobel Prize winners have been members. The Society is based in Research Triangle Park, North Carolina. www.sigmaxi.org. On Twitter: @SigmaXiSociety

DONATE NOW

SOCIAL MEDIA STREAM